Consumers are fighting the tide of Big Advertising with ad blockers, ad-free subscriptions, and calls for regulation against disruptive marketing. Marketing today—and tomorrow—will be on their terms. As a brand marketer, are you ready to deliver accordingly? Inspired by his bestselling book Friction Fatigue, listen in as Lippe Taylor's CEO Paul Dyer sits down with marketing executives to discuss today's best in class marketing campaigns and 'frictionless' frameworks to help build your brand in an era in which advertising is no longer the answer. With each episode featuring behind-the-scenes stories and expert insights, Frictionless Marketing helps decision-makers like you prepare for a future in which the consumer rules.
https://lippetaylor.com
episode 63: Trista Morrison, Chief Corporate Affairs Officer at Voyager Therapeutics
We're excited to have Trista Morrison, Chief Corporate Affairs Officer and Chief of Staff to the CEO at Voyager Therapeutics, on our show today. Trista is a seasoned biopharmaceutical executive advisor with over two decades of experience in corporate affairs and stakeholder management. Her career spans a range of significant roles, including Chief Corporate Affairs Officer for Saniona and Vice President of Communications and Patient Advocacy for Sobi in North America.
At Voyager Therapeutics, Trista plays a pivotal role in shaping the company's strategic vision, managing investor relations, and driving corporate communications. She has a rich history in facilitating effective communications at various stages of company development, from preclinical to commercial, and has worked extensively in both the U.S. and Europe. Trista's expertise extends to areas such as DE&I, corporate social responsibility, and patient advocacy, reflecting her comprehensive approach to corporate affairs.
In this episode, Trista shares her extensive experience, tracing her journey from her early days in public relations agencies to her current leadership position at Voyager. She delves into the nuances of storytelling in the biopharma industry, the transition from reporter to corporate leader, and the integration of communications with corporate strategy. Trista offers a unique perspective on the evolution of corporate communications in biopharma and provides insights into the challenges and opportunities associated with this dynamic field.
Join us in exploring these fascinating topics and more with Trista Morrison.